Insider Trading & Ownership of Atlas Venture Fund XI, L.P.

Location: Cambridge, MA
Summary: The estimated value of insider holdings of Atlas Venture Fund XI, L.P. is at least $389,185,935 dollars as of 10 Feb 2025. Atlas Venture Fund XI, L.P. is the 10%+ Owner of Dyne Therapeutics, Inc. and owns shares of Dyne Therapeutics, Inc. (DYN) stock worth about $165.71M. Atlas Venture Fund XI, L.P. is the 10%+ Owner of Third Harmonic Bio, Inc. and owns shares of Third Harmonic Bio, Inc. stock worth about $140.11M. Atlas Venture Fund XI, L.P. is the 10%+ Owner of Day One Biopharmaceuticals, Inc. and owns shares of Day One Biopharmaceuticals, Inc. (DAWN) stock worth about $70.24M. Atlas Venture Fund XI, L.P. is the 10%+ Owner of Ikena Oncology, Inc. and owns shares of ImageneBio, Inc. (IMA) stock worth about $11.37M. Atlas Venture Fund XI, L.P. is the 10%+ Owner of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $1.76M.
Signature: Atlas Venture Fund XI, L.P., By: Atlas Venture Associates XI, L.P., its general partner, by Atlas Venture Associates XI, LLC, its general partner, By: /s/ Ommer Chohan, Chief Financial Officer
All Insider Reports: All Insider Reports

Notify me when Atlas Venture Fund XI, L.P. files a new Insider Trading report.

Ownership of Atlas Venture Fund XI, L.P.

Symbol	Company	Relationship	Holdings Value	Report Period
DYN	Dyne Therapeutics, Inc.	10%+ Owner	$165,705,095	26 Feb 2024
THRD	Third Harmonic Bio, Inc.	10%+ Owner	$140,112,473	01 Nov 2024
DAWN	Day One Biopharmaceuticals, Inc.	10%+ Owner	$70,239,762	12 Dec 2022
IMA	Ikena Oncology, Inc.	10%+ Owner	$11,365,976	30 Mar 2021
XLO	Xilio Therapeutics, Inc.	10%+ Owner	$1,762,629	08 Feb 2024
SION	Sionna Therapeutics, Inc.	10%+ Owner		10 Feb 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.